Preceding this report, a proof-of-concept [14] .
1.Introduction
Skeletal dysplasias (SDs) afflict an estimated 4 million people worldwide. This is a heterogeneous group of genetic disorders affecting skeletal development. It is a highly specialised area with less than 100 experts worldwide. Diagnoses are largely based on clinical examination of the patient and x-ray images of various skeletal regions. To-date over 370 conditions have been identified. Over the last decade, the genetic defects responsible for many SDs have been discovered. However, the molecular mechanisms are still only understood for a minority of the diseases.
Skeletal dysplasias are congenital conditions of abnormal development of the skeleton. There is no exact definition of what constitutes a SD, as is the nature of biology. The disorders considered by SD experts are generally defined by having either primarily skeletal effects, or significant skeletal effects; mostly leading to shorter than normal stature; and having a genetic/heritable cause. In fact, the disorders which are classified as SDs change over time: disorders previously considered distinct are merged, disorders given one name are split, disorders are no longer considered SDs, disorders are (newly) recognised and added, and other disorders are included.
Of the 370 distinct entities recognised, many are extremely rare. Determining the type and/or cause is important for treatment and counselling. Diagnoses are typically based on examination of X-rays (radiology) with experts in the field pattern-matching a patient to their internal knowledge or reference sources.
The discovery of the underlying genetic defect of many SDs has caused some re-examination of diagnoses and categories. What were once considered distinct disorders have, in some cases, since been found to be caused by the same gene. However, there are also examples of genes where different mutations cause distinctly different SDs, either due to severity of effect, or to, for example, multifunctional proteins where some mutations may disrupt only some functions.
Using the REAMS database, clinicians can search for exemplar x-rays when diagnosing patients presenting with SD. To-date, REAMS [4] is the only system available for searching exemplar x-rays of known SD conditions by feature using text querying. OMIM [8] is a popular nosology database which could be used to classify SDs. However, there are significant disadvantages to the relevant subset of OMIM: the clinical and diagnostic information is somewhat limited and does not conform to a strict terminology. They are also not written by experts in the SD field. Attempts to provide a broader database of knowledge remains unresolved [see 5]. To fully understand the interconnectedness of overlapping phenotypes contained in the REAMS database we have developed a 3D visualisation of the REAMS database.
To test the accuracy and usefulness of the 3D visualisation, the 6 known type II collagenopathies were colour coded to distinguish their location within the larger REAMS database. Distinct clustering was detected. However, we also discovered 10 non type II collagenopathy conditions that share 2 or more common clinical and/or radiographic features with at least 1 of the 6 known type II collagenopathy conditions. This allowed us to confirm and quantify the phenome overlap among the type II collagenopathies as originally predicted by [14] . This study reports on the phenome overlap revealed by the visualisation schema used and how this may be used for further analysis of the REAMS database.
The REAMS Database
The REAMS database includes 3436 x-ray case studies of 221 of the 370 known SD conditions. It divides its findings into the categories: age, disease, abnormality, part of the anatomy affected, and site on the body. It presents an easy to navigate visual interface for diagnostic analysis of case study SD's for practitioners and microbiologists alike (see figure 1 ). The REAMS database does not show links between diseases related by either clinical or radiographic feature. 
Type II Collagenopathy Grouping
In 1994 [14, p61] showed how, despite "phenotypic differences, the type II collagenopathies share many clinical and radiographic manifestations." Their radiographic patterns were recognised before they were linked to abnormalities common to type II collagen biosyntheses. To-date, the relationship between genotype and phenotype has not been well understood. However, recent developments in molecular biology show some pathomechanisms leading to groups of bone dysplasias that had previously been delineated by their clinical and radiographic manifestations. Hence, once distinct entities can now be shown to represent parts of a continuous genotype spectrum.
The 6 known type II collagenopathy clustering has not been previously demonstrated as a distinct subset of the larger collection of SD conditions in a comprehensive manner. In so doing, [14' s] findings and are confirmed.
Phenomic Overlap
The benefits of demonstrating the linking of shared phenotypic features in a database of clinical diagnostics was recently revealed by [12] . They used a database of medical diagnoses that was constructed from a large collection of clinical and radiographic records. From this, several novel relationships were detected at the phenome level. They illustrated the power of phenomics by revealing links between conditions that were thought to be distinct, suggesting that they share a genetic basis. Their results imply that the human phenome can be viewed as a landscape of interrelated diseases, reflecting overlapping molecular causation [11, p103] . Prior to this, the human phenome has been split into discrete entities or diseases. Searching for common pathogenic mechanisms that link diseases together, on the other hand, has the potential to redefine how we classify diseases in general. Following from this, phenomics may also reveal genetic links among disease hitherto unknown [11] .
Without going in to the splitter and lumper debate (articulated by [9] ) on pathogenic and phenotypic overlaps, phenotypic overlap is often a good predictor of functional relatedness of the underlying genes [1] . Both arguments are essentially correct, in the manner that the particle-wave duality theory of light helps us to understand its different properties better. Hence, it is worth studying phenotypic overlap as a general indicator of shared pathogenesis [11] . This has been validated in several recent studies [3; 6; 16] . [11, p105] argue that one might use a "phenotype network for the design of genetic mapping …[thus linking] seemingly disparate phenotypes." It is on this basis that we set about visualising the 6 known type II collagenopathies within the larger collection of SD conditions contained in the REAMS database.
3D JAVA Visualisation graph
To produce the 3D visualisation graphs, we developed a JAVA application to generate a 3D VRML file for browsing in Internet Explorer or other compliant browser. The JAVA application generates a node array with relative spring distance sorts between nodes. The embedded spring forces between nodes follow the formula: double distanceSquared = deltaX*deltaX + deltaY*deltaY + deltaZ*deltaZ; double distance = Math.sqrt(distanceSquared).
The nodes are specified in a table of from-to relationships generated in Excel from a REAMS database dump as a txt file and read by the JAVA main file. Links are iteratively built between nodes. Nodes are placed within a restricted distance from the origin. The camera is set at a distance found by averaging the distance of all nodes from the origin so all nodes can be seen in the final view. Node lookup tables are created for storing the respective coordinates. The lookup tables are used to generate an array which is parsed to a VRML format and output as a *wrl file for viewing in a browser.
We are currently working on a more automated version which will be able to dynamically lookup mySQL tables for real-time querying and viewing using the MORCEGO visualisation widget [17] .
Visualising the Phenome Overlap
There are 370 known SD conditions, including the type II collagenopathies. The 6 type II collagenopathies identified by [14] Following the visualisation, we found 10 non type II collagenopathy conditions shared 2 or more of the same features of at least one of the type II collagenopathies (see figure 3 & 4 Table 1 ). [14] identified the 6 known type II collagenopathies in 1994. Our 3D visualisation of their clustering within a dataset containing also the 50 most common SD has confirmed their interconnectedness. It also visually defined 10 non type II collagenopathies with shared features. Table 1 . shows the conventional method for comparing shared values. However, it is difficult to conceptualise the interlinking of shared values between the given constants. Visualisation, on the other hand, provided a quick overview of these links in a manner from which visual patterns, in the from of clustering, could be readily identified [see 15; 2; 13] . In turn, this may provide the impetus to revisit the naming of groups of diseases with the overlapping phenotypic information identified by this study. Further genetic testing of the 10 related non type II collagenopathies may determine a biochemical link also. 
Discussion

Conclusion and Future Directions
The REAMS database has been compiled over a number of years. It contains more than 7000 x-ray exemplar images from which have been drawn the feature sets for the SDs included. Other databases of SD case studies exist (such as the Lachman Classification tables, LA Cedars-Sinai). By expanding our core database with the information from the other databases, we will be able to report more conclusive results. Nevertheless, this early pilot study demonstrates the potential for the use of 3D visualisation to quickly and efficiently identify potential interconnectedness between shared clinical and radiological terms associated with SDs, not easily decipherable using tables of values alone.
The need for alternative methods for identifying overlap of phenotypic data, such as that reported here, is supported by the recent work of [12] and others [7; 10; 11] . Their collective work suggests that, while the OMIM database is still the most widely used database in the field of phenomics, much can be improved by exploring phenotype overlap. Moreover, analysis of phenotype descriptor links will yield more useful overlap and potential re-grouping of disease types than the free text search ability of the OMIM database in its current form. In other words, the study of the phenome should be regarded as a study of the networked interrelatedness of diseases and their traits rather than distinct disease entities. By visualising these links, the phenomic landscape may uncover many more pathogenic links previously unknown leading to improved diagnostic practices.
